Home FDA OKs Merck hepatitis C drug, adding to patient choices
 

Keywords :   


FDA OKs Merck hepatitis C drug, adding to patient choices

2016-01-29 02:48:54| Biotech - Topix.net

Patients with hepatitis C have yet another advanced treatment option, as the Food and Drug Administration on Thursday approved a new once-a-day pill developed by drugmaker Merck. The FDA said Merck can begin marketing Zepatier for patients with two of the subtypes the liver-destroying virus, types 1 and 4. The combination pill includes the medications elbasvir and grazoprevir, which attack the virus in two different ways.

Tags: drug adding patient choices

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news

»
26.11GibsonSG
26.11Dimarzio DP419 area67 2
26.11110
26.11
26.11tnqnp671
26.11SchucoClassic
26.11 DX 3 25CM
26.112018
More »